Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) EPS (Weighted Average and Diluted) (2023 - 2025)

Metagenomi (MGX) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.59 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 6.35% to -$0.59 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.36, a 9.92% increase, with the full-year FY2025 number at -$2.36, changed 0.0% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.59 for Q4 2025 at Metagenomi, down from -$0.55 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.29 in Q2 2024 to a low of -$5.82 in Q3 2023.
  • A 3-year average of -$2.09 and a median of -$0.66 in 2025 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 92.41% in 2024, then crashed 86.21% in 2025.
  • Metagenomi's EPS (Weighted Average and Diluted) stood at -$5.67 in 2023, then soared by 88.89% to -$0.63 in 2024, then grew by 6.35% to -$0.59 in 2025.
  • Per Business Quant, the three most recent readings for MGX's EPS (Weighted Average and Diluted) are -$0.59 (Q4 2025), -$0.55 (Q3 2025), and -$0.54 (Q2 2025).